Loading
Total declarations
Company
▲ Purchases (12 ops.)
▼ Sales (0 ops.)
Latest filing published 01 May 2026 for Processa Pharmaceuticals, Inc., €3,465. Read the official filing
Filing timeline
BuySalePatrick Lin
Insider track record
Disclosed buys
12
Disclosed sells
0
T+90 hit rate
25%
T+90 mean return
-23.0%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Patrick Lin: trading record in brief
Patrick Lin (senior executive) discloses dealings in Processa Pharmaceuticals, Inc. to SEC (Form 4). The record holds 21 filings, for trades running from 21 June 2021 to 30 April 2026.
The open-market record is one-sided, with 12 purchases worth €123k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 4 share grants and 5 option exercises. 2026 to date brings 3 purchases and no sales.
In size, the median ticket on the buying side is €8,049. Scaled by market value, the purchases weigh a median 0.068% of market cap (sample: 3 purchases). Clusters matter here: 6 out of 11 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.
Most recently, on 1 May 2026, the filings show an open-market purchase worth €3,465 in Processa Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Patrick Lin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations21 total
1,511 shares@ US$2.690.068% mcap1.8% of flowCommon StockSEC:0000897069-26-001004:0
Canonical exit: 29 Jul 2026 (T+90)
1,369 shares@ US$2.970.068% mcap1.7% of flowCommon StockSEC:0000897069-26-000908:0
Canonical exit: 14 Jul 2026 (T+90)
1,603 shares@ US$2.5352.6% of flowCommon StockSEC:0000897069-26-000747:0
Canonical exit: 29 Jun 2026 (T+90)
193 shares0Common StockSEC:0000897069-26-000222:0
14,482 sharesCommon StockSEC:0000897069-25-000795:0
43,500 shares@ US$0.797517.1% of flowCommon StockSEC:0000897069-25-000130:0
Canonical exit: 27 Apr 2025 (T+90)
1,675 sharesCommon StockSEC:0000897069-24-001611:0
1,675 sharesCommon StockSEC:0000897069-24-000921:0
2,500 shares@ US$2.372.8% of flowCommon StockSEC:0000897069-24-000236:0
Canonical exit: 30 Apr 2024 (T+90)
5,000 shares@ US$0.320.8% of flowCommon StockSEC:0000897069-23-001466:0
13,700 shares@ US$0.211.4% of flowCommon StockSEC:0000897069-23-001442:0
12,500 shares@ US$0.804.8% of flowCommon StockSEC:0001567619-23-002400:0
7,601 sharesCommon StockSEC:0001567619-22-015301:0
2,000 shares@ US$1.59452.4% of flowCommon StockSEC:0001567619-22-011300:0
Canonical exit: 15 Aug 2022 (T+90)
1,200 shares@ US$3.12672.7% of flowCommon StockSEC:0001567619-22-008312:0
Canonical exit: 5 Jul 2022 (T+90)
3,000 shares@ US$4.000.16% mcap7.5% of flowCommon StockSEC:0001567619-22-000291:0
Canonical exit: 14 Mar 2022 (T+90)
3,000 shares@ US$4.008.4% of flowCommon StockSEC:0001567619-21-022195:0
Canonical exit: 14 Mar 2022 (T+90)
3,500 shares@ US$4.798611.8% of flowCommon StockSEC:0001567619-21-021708:0
Canonical exit: 3 Mar 2022 (T+90)
4,000 shares@ US$6.02216.2% of flowCommon StockSEC:0001567619-21-016470:0
Canonical exit: 24 Nov 2021 (T+90)
7,601 sharesCommon StockSEC:0001567619-21-014747:0
2,000 shares@ US$6.658.8% of flowCommon StockSEC:0001567619-21-012486:0
Canonical exit: 19 Sept 2021 (T+90)
21 of 21 declarations
